×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ICCC – immucell corporation (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ICCC
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
1/9
11:21 am
iccc
ImmuCell Q4 Earnings Call Highlights [Yahoo! Finance]
Low
Report
ImmuCell Q4 Earnings Call Highlights [Yahoo! Finance]
1/8
04:56 pm
iccc
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 [Yahoo! Finance]
Medium
Report
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025 [Yahoo! Finance]
1/8
04:05 pm
iccc
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
Low
Report
ImmuCell Announces Preliminary, Unaudited Sales Results for Q4 and Full Year of 2025
1/7
08:27 am
iccc
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus [Yahoo! Finance]
Medium
Report
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus [Yahoo! Finance]
1/7
08:10 am
iccc
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
Medium
Report
ImmuCell to Conduct Conference Call with Investors to Discuss Strategic Change in Focus
12/24
01:22 pm
iccc
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain® [Yahoo! Finance]
Neutral
Report
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain® [Yahoo! Finance]
12/24
01:05 pm
iccc
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
Neutral
Report
ImmuCell Announces Strategic Focus on First Defense® After Receiving an FDA Incomplete Letter for Re-Tain®
12/4
07:03 pm
iccc
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth [Yahoo! Finance]
Medium
Report
ImmuCell's Two-Product Edge in Cattle Health Fuels Growth [Yahoo! Finance]
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
1/8
04:13 pm
iccc
Form 8-K IMMUCELL CORP /DE/ For: Jan 08
Low
Report
Form 8-K IMMUCELL CORP /DE/ For: Jan 08
12/29
08:00 am
iccc
Form 8-K IMMUCELL CORP /DE/ For: Dec 24
Low
Report
Form 8-K IMMUCELL CORP /DE/ For: Dec 24
12/4
04:12 pm
iccc
Form 4/A IMMUCELL CORP /DE/ For: Dec 03 Filed by: te Boekhorst Paul Francis Olivier
Medium
Report
Form 4/A IMMUCELL CORP /DE/ For: Dec 03 Filed by: te Boekhorst Paul Francis Olivier
12/3
04:14 pm
iccc
Form 4 IMMUCELL CORP /DE/ For: Dec 02 Filed by: te Boekhorst Paul Francis Olivier
Low
Report
Form 4 IMMUCELL CORP /DE/ For: Dec 02 Filed by: te Boekhorst Paul Francis Olivier
11/28
08:13 am
iccc
Form 4 IMMUCELL CORP /DE/ For: Nov 25 Filed by: Tomsche David Scott
Low
Report
Form 4 IMMUCELL CORP /DE/ For: Nov 25 Filed by: Tomsche David Scott
11/20
04:36 pm
iccc
Form SCHEDULE 13D/A IMMUCELL CORP /DE/ Filed by: Knudsen Ejnar A III
Low
Report
Form SCHEDULE 13D/A IMMUCELL CORP /DE/ Filed by: Knudsen Ejnar A III
11/12
08:43 am
iccc
Form 4 IMMUCELL CORP /DE/ For: Nov 07 Filed by: te Boekhorst Paul Francis Olivier
Low
Report
Form 4 IMMUCELL CORP /DE/ For: Nov 07 Filed by: te Boekhorst Paul Francis Olivier
11/7
07:41 am
iccc
Form 3 IMMUCELL CORP /DE/ For: Oct 29 Filed by: te Boekhorst Paul Francis Olivier
Medium
Report
Form 3 IMMUCELL CORP /DE/ For: Oct 29 Filed by: te Boekhorst Paul Francis Olivier
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
1/21
ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Year Ended December 31, 2019
6.9%
5/7 ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019 5.8%
4/2 ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020 3.5%
2/19 ImmuCell Corporation (ICCC) CEO Michael Brigham on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.5%
8/6 ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019 2.6%
2/13 ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019 2.4%
4/14 ImmuCell Receives $938,000 in Support under the Paycheck Protection Program 2.0%
9/11 ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain™ 1.9%
4/28 Form DEF 14A IMMUCELL CORP /DE/ For: Jun 10 1.5%
1/22 Form 8-K IMMUCELL CORP /DE/ For: Jan 21 1.2%
5/7 ImmuCell to Announce Unaudited Financial Results for First Quarter of 2019 5.8%
4/2 ImmuCell Announces Preliminary, Unaudited Product Sales Results for the Quarter Ended March 31, 2020 3.5%
2/19 ImmuCell Corporation (ICCC) CEO Michael Brigham on Q4 2019 Results - Earnings Call Transcript [Seeking Alpha] 3.5%
8/6 ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2019 2.6%
2/13 ImmuCell to Announce Preliminary Financial Results for the Year Ended December 31, 2019 2.4%
4/14 ImmuCell Receives $938,000 in Support under the Paycheck Protection Program 2.0%
9/11 ImmuCell Announces an Agreement Covering the Formulation and Aseptic Filling of Syringes for Re-Tain™ 1.9%
4/28 Form DEF 14A IMMUCELL CORP /DE/ For: Jun 10 1.5%
1/22 Form 8-K IMMUCELL CORP /DE/ For: Jan 21 1.2%
TOP News Decliners
3/2
Form 4 IMMUCELL CORP /DE/ For: Feb 27 Filed by: Tomsche David Scott
-10.1%
2/18 Form 8-K IMMUCELL CORP /DE/ For: Feb 18 -8.5%
3/11 ImmuCell Announces Refinancing of its Bank Debt -7.4%
5/10 Form DEFR14A IMMUCELL CORP /DE/ -3.3%
9/11 Form 8-K IMMUCELL CORP /DE/ For: Sep 05 -3.3%
9/5 ImmuCell Co. (NASDAQ: ICCC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.2%
3/27 Form S-8 IMMUCELL CORP /DE/ -3.0%
5/14 ImmuCell Corporation's (ICCC) CEO Michael Brigham on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.0%
12/12 Form 4 IMMUCELL CORP /DE/ For: Dec 09 Filed by: Brockmann Bobbi Jo -1.8%
1/28 Form SC 13G IMMUCELL CORP /DE/ Filed by: WELLINGTON MANAGEMENT GROUP LLP -1.6%
2/18 Form 8-K IMMUCELL CORP /DE/ For: Feb 18 -8.5%
3/11 ImmuCell Announces Refinancing of its Bank Debt -7.4%
5/10 Form DEFR14A IMMUCELL CORP /DE/ -3.3%
9/11 Form 8-K IMMUCELL CORP /DE/ For: Sep 05 -3.3%
9/5 ImmuCell Co. (NASDAQ: ICCC) was upgraded by analysts at ValuEngine from a "hold" rating to a "buy" rating. -3.2%
3/27 Form S-8 IMMUCELL CORP /DE/ -3.0%
5/14 ImmuCell Corporation's (ICCC) CEO Michael Brigham on Q1 2019 Results - Earnings Call Transcript [Seeking Alpha] -2.0%
12/12 Form 4 IMMUCELL CORP /DE/ For: Dec 09 Filed by: Brockmann Bobbi Jo -1.8%
1/28 Form SC 13G IMMUCELL CORP /DE/ Filed by: WELLINGTON MANAGEMENT GROUP LLP -1.6%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: